靶向短程放疗联合小鼠直肠癌原位模型的建立
研究将小鼠结肠38-荧光素酶肿瘤细胞注入同系小鼠直肠壁,并在肿瘤对侧放置临床级钛基准标记以实现精准靶向。植入后9天给予5次连续每日5 Gy的影像引导适形小动物照射短程放疗,结果显示肿瘤负荷降低、总生存改善且无明显全身毒性,并重现了人类直肠癌放疗后的组织学与流式细胞学变化。
要点
- 小鼠直肠癌原位模型联合临床级钛基准标记可实现精准短程放疗靶向。
- 短程放疗方案为5次连续每日5 Gy,于植入后9天给予。
- 放疗后肿瘤负荷降低、总生存改善,无明显全身毒性。
核心结论
- 研究建立了靶向小鼠直肠癌原位肿瘤的基准标记方法,采用分次且临床相关的短程放疗方案,产生的放疗反应与人类直肠癌观察到的相似。
- 该模型可用于进一步探索放疗剂量与分割方案,并测试联合治疗。
研究设计与样本
- 将小鼠结肠38-荧光素酶肿瘤细胞注入同系小鼠直肠壁,并在肿瘤对侧放置基准标记以界定肿瘤。
- 植入后9天给予短程放疗方案:5次连续每日5 Gy,由影像引导适形小动物照射器实施。
- 监测肿瘤负荷与生存,并在不同时间点对受照与未治疗肿瘤进行组织学和流式细胞学分析。
主要发现
- 对原位直肠肿瘤实施短程放疗后肿瘤负荷降低、总生存改善,且无明显全身毒性迹象。
- 该治疗方案导致肿瘤细胞密度显著降低、纤维化和透明质酸产生增加,重现了人类癌症中观察到的短程放疗诱导效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Orthotopic tumors more closely recapitulate human cancers than do ectopic models; however, precision targeting of such internal tumors for radiation therapy (RT) without inducing systemic toxicity remains a barrier. We developed an innovative murine orthotopic rectal tumor model where the insertion of clinical grade titanium fiducial clips on opposing sides of the rectal tumor allowed for targeted administration of short-course radiation therapy (SCRT). With this novel approach, clinically relevant RT regimens can be administered to orthotopic tumors to explore the biology and efficacy of radiation alone or as a combination therapy in a murine model that closely recapitulates human disease. METHODS AND MATERIALS: Murine Colon 38-luciferase tumor cells were injected into the rectal wall of syngeneic mice, and fiducial clips were applied to demarcate the tumor. An SCRT regimen consisting of 5 consecutive daily doses of 5 Gy delivered by an image-guided conformal small animal irradiator was administered 9 days after implantation. Tumor burden and survival were monitored along with histological and flow cytometric analyses on irradiated versus untreated tumors at various time points. RESULTS: SCRT administered to orthotopic rectal tumors resulted in a reduction in tumor burden and enhanced overall survival with no apparent signs of systemic toxicity. This treatment paradigm resulted in significant reductions in tumor cellularity and increases in fibrosis and hyaluronic acid production, recapitulating the SCRT-induced effects observed in human cancers. CONCLUSIONS: We have established a means to target murine orthotopic rectal tumors using fiducial markers with a fractionated and clinically relevant SCRT schedule that results in an RT response similar to what is observed in human rectal cancer. We also validated our model through examining various parameters associated with human cancer that are influenced by irradiation. This model can be used to further explore RT doses and scheduling, and to test combinatorial therapies.
引用
- Uccello TP, Kintzel SA, Mills BN, et al. Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy. Adv Radiat Oncol. 2021. PMID: 35036637. doi:10.1016/j.adro.2021.100867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。